Larson Financial Group LLC Boosts Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Larson Financial Group LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1,685.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 375 shares of the company’s stock after acquiring an additional 354 shares during the period. Larson Financial Group LLC’s holdings in HCA Healthcare were worth $125,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of HCA. Centerpoint Advisors LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter worth $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at $27,000. Bruce G. Allen Investments LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at $28,000. LifeSteps Financial Inc. purchased a new position in HCA Healthcare during the first quarter valued at $33,000. Finally, Rise Advisors LLC purchased a new position in shares of HCA Healthcare in the first quarter worth about $36,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.5 %

NYSE HCA traded down $1.56 on Wednesday, hitting $315.35. 1,433,180 shares of the company were exchanged, compared to its average volume of 1,106,624. The firm has a market capitalization of $82.59 billion, a P/E ratio of 15.79, a price-to-earnings-growth ratio of 1.43 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $344.20. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The company’s 50 day moving average price is $326.96 and its 200-day moving average price is $319.44.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the prior year, the business earned $4.93 earnings per share. The company’s revenue was up 11.2% on a year-over-year basis. Analysts predict that HCA Healthcare, Inc. will post 20.97 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were paid a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.84%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 1,600 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 12,397 shares of company stock worth $3,921,929. Insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of analyst reports. Oppenheimer lifted their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Royal Bank of Canada boosted their price objective on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. TD Cowen reduced their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Robert W. Baird started coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective on the stock. Finally, StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $326.53.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.